Literature DB >> 24831047

Antineoplastic drug exposure in an ambulatory setting: a pilot study.

Christopher R Friese1, Cristin McArdle, Ting Zhao, Duxin Sun, Ivan Spasojevic, Martha Polovich, Marjorie C McCullagh.   

Abstract

BACKGROUND: Exposure to antineoplastic drugs confers health risks to workers, yet little is known about the exposure after a drug spill, nor has the relationship between exposure and organizational factors such as staffing and work environment been studied.
OBJECTIVE: The aim of this study was to evaluate drug spills prospectively using biological measures and correlate drug spills with organizational factors.
METHODS: Prospective questionnaires with 8-hour timed urine samples were collected from nursing and pharmacy personnel who reported drug spill events in 1 academic health center's infusion center. Urine was collected similarly from workers who did not report a spill. Liquid chromatography tandem mass spectrometry techniques identified detectable drug levels. After the prospective sampling period, workers were surveyed on workloads, practice environment, and safety behaviors.
RESULTS: From 81 eligible individuals, 40 participated in the prospective study and 19 completed retrospective questionnaires. Four spills were reported by 9 personnel, as multiple employees were exposed to drug spills. Four participants who reported a spill showed detectable levels of antineoplastic drugs. Four participants who did not report a spill had detectable levels of docetaxel. Compared with respondents who did not report a spill, collegial relations with physicians were significantly poorer for workers who reported spills.
CONCLUSIONS: The study protocol successfully captured drug spill reports and biological samples. Workers have detectable levels of antineoplastic drugs through both drug spills and environmental contamination. IMPLICATIONS FOR PRACTICE: Multisite research studies and practice-based quality improvement approaches are needed to improve adherence to personal protective equipment use and safe handling procedures.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24831047      PMCID: PMC4232489          DOI: 10.1097/NCC.0000000000000143

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  20 in total

Review 1.  Biological and environmental monitoring of hospital personnel exposed to antineoplastic agents: a review of analytical methods.

Authors:  Roberta Turci; Cristina Sottani; Giuseppe Spagnoli; Claudio Minoia
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-06-15       Impact factor: 3.205

2.  Nurses' use of hazardous drug-handling precautions and awareness of national safety guidelines.

Authors:  Martha Polovich; Susan Martin
Journal:  Oncol Nurs Forum       Date:  2011-11       Impact factor: 2.172

3.  Guidelines for the safe handling of hazardous drugs: consensus recommendations.

Authors:  Bruce W Chaffee; John A Armitstead; Bona E Benjamin; Michael C Cotugno; Ryan A Forrey; Barbara L Hintzen; Trista Pfeiffenberger; James G Stevenson
Journal:  Am J Health Syst Pharm       Date:  2010-09-15       Impact factor: 2.637

4.  Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers.

Authors:  Thomas H Connor; D Gayle DeBord; Jack R Pretty; Marc S Oliver; Tracy S Roth; Peter S J Lees; Edward F Krieg; Bonnie Rogers; Carmen P Escalante; Christine A Toennis; John C Clark; Belinda C Johnson; Melissa A McDiarmid
Journal:  J Occup Environ Med       Date:  2010-10       Impact factor: 2.162

5.  The impact of teamwork on missed nursing care.

Authors:  Beatrice J Kalisch; Kyung Hee Lee
Journal:  Nurs Outlook       Date:  2010 Sep-Oct       Impact factor: 3.250

6.  Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment.

Authors:  Jack R Pretty; Thomas H Connor; Ivan Spasojevic; Kristine S Kurtz; Jeffrey L McLaurin; Clayton B'Hymer; D Gayle Debord
Journal:  J Oncol Pharm Pract       Date:  2010-12-23       Impact factor: 1.809

7.  Practice environments of nurses employed in ambulatory oncology settings: measure refinement.

Authors:  Christopher R Friese
Journal:  Oncol Nurs Forum       Date:  2012-03       Impact factor: 2.172

8.  Assessment of potential exposure to antineoplastic agents in the health care setting.

Authors:  J M Stellman; B M Aufiero; R N Taub
Journal:  Prev Med       Date:  1984-05       Impact factor: 4.018

9.  Structures and processes of care in ambulatory oncology settings and nurse-reported exposure to chemotherapy.

Authors:  Christopher R Friese; Laurel Himes-Ferris; Megan N Frasier; Marjorie C McCullagh; Jennifer J Griggs
Journal:  BMJ Qual Saf       Date:  2011-08-16       Impact factor: 7.035

10.  2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy.

Authors:  Michael N Neuss; Martha Polovich; Kristen McNiff; Peg Esper; Terry R Gilmore; Kristine B LeFebvre; Lisa Schulmeister; Joseph O Jacobson
Journal:  J Oncol Pract       Date:  2013-03       Impact factor: 3.840

View more
  7 in total

1.  Liquid release as a source of potential drug exposure during the handling of intravenous infusions in nursing.

Authors:  Verena Segner; Renate Kimbel; Philipp Jochems; André Heinemann; Stephan Letzel; Daniel Wollschläger; Bernd Roßbach
Journal:  Int Arch Occup Environ Health       Date:  2017-01-16       Impact factor: 3.015

2.  Personal Protective Equipment Use and Hazardous Drug Spills Among Ambulatory Oncology Nurses

Authors:  Bei He; Kari Mendelsohn-Victor; Marjorie McCullagh; Christopher Friese
Journal:  Oncol Nurs Forum       Date:  2017-01-06       Impact factor: 2.172

3.  Lessons Learned From a Practice-Based, Multisite Intervention Study With Nurse Participants.

Authors:  Christopher R Friese; Kari Mendelsohn-Victor; Pamela Ginex; Carol M McMahon; Alex J Fauer; Marjorie C McCullagh
Journal:  J Nurs Scholarsh       Date:  2017-01-18       Impact factor: 3.176

Review 4. 

Authors:  Céline Poupeau; Christel Roland; Jean-François Bussières
Journal:  Can J Hosp Pharm       Date:  2016-10-31

5.  Hazardous Drug Exposure: Case Report Analysis From a Prospective, Multisite Study of Oncology Nurses' Exposure in Ambulatory Settings.

Authors:  Christopher R Friese; Mandy Wong; Alex Fauer; Kari Mendelsohn-Victor; Martha Polovich; Marjorie C McCullagh
Journal:  Clin J Oncol Nurs       Date:  2020-06-01       Impact factor: 1.027

6.  Study protocol for the assessment of nurses internal contamination by antineoplastic drugs in hospital centres: a cross-sectional multicentre descriptive study.

Authors:  Antoine Villa; Mathieu Molimard; Emmanuelle Bignon; Béatrice Martinez; Magali Rouyer; Simone Mathoulin-Pelissier; Isabelle Baldi; Catherine Verdun-Esquer; Mireille Canal-Raffin
Journal:  BMJ Open       Date:  2019-11-10       Impact factor: 2.692

Review 7.  Exposure to Antineoplastic Drugs in Occupational Settings: A Systematic Review of Biological Monitoring Data.

Authors:  Veruscka Leso; Cristina Sottani; Carolina Santocono; Francesco Russo; Elena Grignani; Ivo Iavicoli
Journal:  Int J Environ Res Public Health       Date:  2022-03-21       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.